LNA043

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for LNA043, covering 2020-04-17 to 2026-03-30. Get the full timeline:

Most recent: Clinical Trial Update: Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis [Phase 2]